Fulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation | ||
Medical Journal of Viral Hepatitis | ||
Article 3, Volume 7.1, Issue 1, December 2022, Pages 13-14 PDF (151.64 K) | ||
Document Type: Original article | ||
DOI: 10.21608/mjvh.2022.279332 | ||
Authors | ||
Antonio Mastroianni1; Sonia Greco2; Maria Vittoria Mauro3; Roberto Manfredi* 4 | ||
1Department of Infectious Diseases, Annunziata-Mariano Santo-S. Barbara Hospital, Cosenza, Italy | ||
2Department of Infectious Diseases, Annunziata-Mariano Santo-S. Barbara Hospital, Cosenza, Italy. | ||
3Department of Microbiology, Annunziata-Mariano Santo-S. Barbara Hospital, Cosenza, Italy. | ||
4Dept of Infectious Diseases, University of Bologna, S. Orsola Hospital | ||
Abstract | ||
Background: A severe, near-fatal liver failure due to a concomitant acute HBV-HCV infection has been controlled and later fully resolved from a clinical and a virological point of view, by a prompt and appropriate antiviral treatment. | ||
Keywords | ||
Fulminant hepatitis; concomitant HBV-HCV infection; entecavir; sofosbuvir-velpatasvir; favorable outcome | ||
Statistics Article View: 217 PDF Download: 379 |